In abdominal aortic aneurysm (AAA), ALDH2 inhibits aneurysm formation by inhibiting ROS production, reducing vascular inflammation, and attenuating vascular smooth muscle cell apoptosis, suggesting that ALDH2 can serve as a novel treatment option for AAA [149]. Here, ALDH2 is linked to triple-A syndrome.